|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
US
|
NASDAQ
|
|
MEIP
|
MEI Pharma, Inc.
|
US
|
NASDAQ
|
|
MNOV
|
MediciNova, Inc.
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ORGS
|
Orgenesis Inc.
|
US
|
NASDAQ
|
|
OTIC
|
Otonomy, Inc.
|
US
|
NASDAQ
|
|
PULM
|
Pulmatrix, Inc.
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
US
|
NYSE
|